Page last updated: 2024-08-17

edetic acid and motexafin gadolinium

edetic acid has been researched along with motexafin gadolinium in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hashemy, SI; Holmgren, A; Ungerstedt, JS; Zahedi Avval, F1

Other Studies

1 other study(ies) available for edetic acid and motexafin gadolinium

ArticleYear
Motexafin gadolinium, a tumor-selective drug targeting thioredoxin reductase and ribonucleotide reductase.
    The Journal of biological chemistry, 2006, Apr-21, Volume: 281, Issue:16

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cytosol; Disulfides; Dose-Response Relationship, Drug; Edetic Acid; Electrons; Escherichia coli; Humans; Hydrogen Peroxide; Hydrogen-Ion Concentration; Inhibitory Concentration 50; Insulin; Kinetics; Metalloporphyrins; Models, Chemical; NADP; Oxidation-Reduction; Oxidative Stress; Oxygen; Protein Binding; Rats; Reactive Oxygen Species; Ribonucleotide Reductases; Spectrophotometry; Thioredoxin-Disulfide Reductase; Thioredoxins; Time Factors

2006